<DOC>
	<DOCNO>NCT00001093</DOCNO>
	<brief_summary>The purpose study find effective give aggressive anti-HIV therapy patient infect recently HIV . Many doctor recommend patient recently infect HIV begin anti-HIV treatment soon possible . However , early HIV infection yet completely understood , know best approach . This study look effect begin anti-HIV treatment early HIV infection .</brief_summary>
	<brief_title>Outcomes Anti-HIV Therapy During Early HIV Infection</brief_title>
	<detailed_description>Although many researcher recommend initiation aggressive antiretroviral therapy soon possible HIV infection occur , tolerability efficacy approach systemically evaluate . Many feature primary HIV pathogenesis incompletely understood . A complete understanding immune dynamic viral pathogenesis primary HIV infection critical determine optimal treatment intervention strategy . This study evaluate outcome potent antiretroviral therapy initiate different stage primary HIV infection . Thirty-six study patient coenrolled ACTG 371 another treatment protocol . All study drug treatment toxicity management perform accord guideline treatment protocol . An untreated cohort 12 patient also follow study . Patients stratify enrollment accord stage acute early HIV infection . Patients evaluate virologic , immunologic , clinical parameter 96 week . In addition , novel study source partner identification propose . An effort make determine likely source partner ( ) study patient basis patient recall possible exposure . A separate study protocol evaluate source partner .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are least 13 year old . Have acute early HIV infection . The stage HIV infection depend result certain lab test . Exclusion Criteria Patients eligible study : Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Immunity , Cellular</keyword>
	<keyword>Sexual Partners</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Acute Infection</keyword>
</DOC>